The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid - laboratory markers of neurodegenerative diseases

被引：0

作者：

Mares, J. ^{[1
]}

Herzig, R. ^{[1
]}

Stejskal, D. ^{[2
]}

Vavrouskova, J. ^{[2
]}

Hlustik, P. ^{[1
]}

Vranova, H. ^{[1
]}

Burval, S. ^{[1
]}

Zapletalova, J. ^{[1
]}

Pidrman, V. ^{[1
]}

Obereingeru, R. ^{[1
]}

Suchy, A. ^{[1
]}

Vesely, J. ^{[1
]}

Podivinsky, J. ^{[3
]}

Kanovsky, P. ^{[1
]}

机构：

[1] Univ Hosp, Olomouc, Czech Republic

[2] Nemocnice Sternberk, Sternberk, Czech Republic

[3] Neurol Geriatr Med Inst, Moravsky Beroun, Czech Republic

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2009年 / 285卷

关键词：

D O I：

10.1016/S0022-510X(09)70495-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S125 / S125

页数：1

共 50 条

[1] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases
Jan Mares
P. Kanovsky
R. Herzig
D. Stejskal
J. Vavrouskova
P. Hlustik
H. Vranova
S. Burval
J. Zapletalova
V. Pidrman
R. Obereigneru
A. Suchy
J. Vesely
J. Podivinsky
K. Urbanek
Neurological Sciences, 2009, 30
[2] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases
Mares, Jan
Kanovsky, P.
Herzig, R.
Stejskal, D.
Vavrouskova, J.
Hlustik, P.
Vranova, H.
Burval, S.
Zapletalova, J.
Pidrman, V.
Obereigneru, R.
Suchy, A.
Vesely, J.
Podivinsky, J.
Urbanek, K.
NEUROLOGICAL SCIENCES, 2009, 30 (01) : 1 - 7
[3] The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid laboratory markers of neurodegenerative diseases
Mares, J.
Herzig, R.
Urbanek, K.
Hlustik, P.
Vranova, H.
Sladkova, V.
Opavsky, R.
Lubenova, B.
Kollarova, K.
Obereigneru, R.
Sklenarova, J.
Stejskal, D.
Vavrouskova, J.
Zapletalova, J.
Kanovsky, P.
JOURNAL OF NEUROLOGY, 2008, 255 : 195 - 195
[4] The role of the assessment of cystatin C, tau protein and beta-amyloid in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
Mares, J
Kanovsky, P
Herzig, R
Urbanek, K
Hlustik, P
Vranova, H
Sklenarova, J
Bekarek, V
Schneiderka, P
Podivinsky, J
Vavrouskova, J
Stejskal, D
Adamova, K
Zapletalova, J
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 : S23 - S24
[5] Assessment of total tau protein, phospho-tau and beta amyloid in cerebrospinal fluid, an autopsy correlation study
Glosova, L
Hort, J
Bojar, M
Skoda, D
JOURNAL OF NEUROLOGY, 2005, 252 : 105 - 105
[6] Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
Jing Zhang
Hayley A. Mattison
Changqin Liu
Carmen Ginghina
Peggy Auinger
Michael P. McDermott
Tessandra Stewart
Un Jung Kang
Kevin C. Cain
Min Shi
Acta Neuropathologica, 2013, 126 : 671 - 682
[7] Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
Zhang, Jing
Mattison, Hayley A.
Liu, Changqin
Ginghina, Carmen
Auinger, Peggy
McDermott, Michael P.
Stewart, Tessandra
Kang, Un Jung
Cain, Kevin C.
Shi, Min
ACTA NEUROPATHOLOGICA, 2013, 126 (05) : 671 - 682
[8] Tau protein and beta amyloid in cerebrospinal fluid in patients with multiple sclerosis
Talab, R
Valis, M
Andrys, C
Talabova, M
Krejsek, J
JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 189 - 189
[9] Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease
Mandic, Gorana
Markovic, Ivanka
Ostojic, Marija
Stojkovic, Tanja
Misirlic-Dencic, Sonja
Zivanovic-Radnic, Tatjana
Stefanovic, Rodoljub
Bumbasirevic, Marko
Stefanova, Elka
Kostic, Vladimir
VOJNOSANITETSKI PREGLED, 2008, 65 (12) : 901 - 905
[10] Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity
Cerman, J.
Laczo, J.
Vyhnalek, M.
Malinovska, J.
Hanzalova, J.
Hort, J.
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (02) : 173 - 179

← 1 2 3 4 5 →